Applied Therapeutics Inc
APLT
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.86M
Close$
$0.55
435% upside
Current Fair Value
435% upsideUndervalued by 435% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.86 Million |
|---|---|
| Enterprise Value | $5.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.76 |
| Beta | 2.08 |
| Outstanding Shares | 145,559,604 |
Return
| Return on Equity | 3233.16% |
|---|---|
| Return on Assets | -52.77% |
| Return on Invested Capital | -6836.62% |
Valuation & Multiples
| P/E Ratio | -0.83 |
|---|---|
| PEG | 1.14 |
| Price to Sales | - |
| Price to Book Ratio | -0.1 |
| Enterprise Value to Revenue | 5.42 |
| Enterprise Value to EBIT | -0.05 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | -4.46 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 13, 2025
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$333,333
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.9730▲ 413.03% |
|---|---|
| Total Calls | 77,900▼ 78.16% |
| Total Puts | 387,400▲ 28.88% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 40.45%▼ 24.65% |
|---|---|
| Total Invested | $5.93M▼ 89.63% |
| Investors Holding | 54▼ 24.00% |
ESG Score
No data